• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - Opioid Epidemic
Tag:

Opioid Epidemic

News

What is 7-OH? Florida bans potent kratom compound, calling it as addictive as opioids

by Chief Editor August 15, 2025
written by Chief Editor

Florida’s Ban on 7-OH: What’s Next for Kratom and Alternative Medicine?

Florida’s recent emergency ban on 7-hydroxymitragynine (7-OH), a concentrated byproduct of kratom, has sent ripples through the alternative medicine community. Citing immediate dangers to public health, Attorney General James Uthmeier’s move raises important questions about the future of kratom regulation and the broader landscape of natural supplements. What does this mean for consumers, retailers, and the future of alternative wellness?

The 7-OH Ban: A Closer Look

The ban, effective immediately, targets 7-OH products available in various forms like drinks, gummies, and powders. The concern stems from its potent opioid-like effects, with doctors highlighting its addictive nature and potential for overdose. Attorney General Uthmeier emphasized the “immediate danger” prompting the emergency action. This follows Florida’s 2023 restriction on kratom sales to individuals under 21, indicating a growing concern over these substances.

7-OH, though naturally present in kratom leaves, is found in much higher concentrations in isolated or concentrated forms. These concentrated products are often marketed as natural health supplements, masking their potential risks.

What is 7-OH and Why the Concern?

7-OH, or 7-hydroxymitragynine, is an alkaloid found in the kratom plant (mitragyna speciosa). It’s a potent mu-opioid receptor agonist, meaning it interacts with the same brain receptors as opioid drugs. This interaction is what causes the pain-relieving and mood-altering effects, but also the addictive potential.

While traditional kratom use involves consuming the leaves, 7-OH extracts concentrate this compound, leading to stronger and potentially more dangerous effects. Some experts, like U.S. Drug and Food Administration Commissioner Martin Makary, fear 7-OH “may be the fourth wave of the opioid epidemic.”

The Future of Kratom Regulation: A Patchwork Approach?

The Florida ban underscores the complex and evolving regulatory landscape surrounding kratom and its derivatives. While some states and municipalities have embraced regulation, others are opting for outright bans. This creates a patchwork of laws, making it challenging for consumers and businesses alike. Will we see a push for federal regulation to create a more uniform approach?

The American Kratom Association, a consumer advocacy group, advocates for the Kratom Consumer Protection Act, which aims to regulate kratom products, ensuring safety and transparency. Several states have adopted this act, offering a middle ground between outright bans and unregulated sales.

Pro Tip: Always research the kratom laws in your state and local area before purchasing or using any kratom products.

Industry Response and the Road Ahead

The ban hasn’t been without opposition. Proponents of 7-OH argue against the emergency scheduling, claiming the risks are overstated and that the decision is driven by kratom industry competition. Groups like the 7-HOPE alliance and the Holistic Alternative Recovery Trust are actively pushing back against the ban, citing a lack of data supporting its dangers.

Jackie Subeck, founder of the 7-HOPE alliance, stated, “This is all a manufactured crisis by the kratom industry because they are losing market share every day to 7-OH.” This highlights the complex dynamics and conflicting interests within the industry.

Expect legal challenges and further legislative action in the coming months. The debate will likely center on balancing public safety with individual access to alternative wellness options.

The Retailer’s Dilemma

For retailers in Florida, the immediate impact is clear: remove 7-OH products from shelves or face potential enforcement action. Agriculture Commissioner Wilton Simpson has warned retailers to comply, promising inspections and seizures of non-compliant products. This sudden shift leaves many businesses scrambling to adapt and re-evaluate their product offerings.

Beyond the Ban: Emerging Trends in Alternative Wellness

The controversy surrounding 7-OH highlights a broader trend: increasing scrutiny of alternative wellness products. As the market for natural supplements grows, so does the need for greater regulation and scientific validation. Expect to see increased research into the safety and efficacy of various compounds, as well as stricter labeling requirements.

Did you know? The global market for herbal supplements is projected to reach over $129 billion by 2030, according to a report by Grand View Research. This growth underscores the increasing consumer interest in natural health solutions.

The focus will likely shift towards evidence-based practices and products that have undergone rigorous testing. This could lead to a more standardized and reliable market for alternative wellness, benefiting both consumers and reputable businesses.

FAQ: Understanding the 7-OH Ban

What is 7-OH?
It’s a concentrated alkaloid found in the kratom plant, known for its potent opioid-like effects.
Why was 7-OH banned in Florida?
Due to concerns about its addictive nature and potential for overdose.
Is kratom banned in Florida?
No, but its sale to individuals under 21 is prohibited.
What should retailers do?
Immediately remove all 7-OH products from their shelves.
What’s next for 7-OH regulation?
Expect legal challenges and further legislative action, potentially leading to more comprehensive regulations.

Reader Question: What are your thoughts on the 7-OH ban? Share your opinions in the comments below!

Explore more articles on alternative medicine and wellness here. Stay informed and make informed choices about your health!

August 15, 2025 0 comments
0 FacebookTwitterPinterestEmail
News

NC launches campaign to reduce stigma around substance use

by Chief Editor July 29, 2025
written by Chief Editor

Breaking the Chains of Stigma: The Future of Substance Use Disorder Treatment

Substance use disorder affects millions, yet stigma remains a formidable barrier to treatment. Imagine a future where understanding and compassion replace judgment, where evidence-based treatments are readily available, and recovery is celebrated. This future is not a distant dream but a tangible goal, driven by campaigns like North Carolina’s Unshame NC and evolving approaches to treatment.

The Enduring Power of Empathy: Humanizing the Narrative

The Unshame NC campaign highlights a crucial element in battling stigma: personal stories. By sharing experiences, individuals can break down misconceptions and foster empathy. This narrative shift is vital because, as First Lady Anna Stein eloquently stated, “People living with a substance use disorder are essential threads in the fabric of our communities.”

Did you know? Studies show that exposure to personal stories of recovery significantly reduces stigma and increases support for treatment options.

We can expect to see more widespread use of storytelling in public health campaigns. The future of destigmatization lies in amplifying diverse voices and creating safe spaces for open dialogue. Expect social media, documentaries, and community events to feature real people sharing their journeys, fostering connection and dismantling stereotypes.

Medication-Assisted Treatment: Overcoming Resistance and Expanding Access

Medication-assisted treatment (MAT), involving drugs like buprenorphine, methadone, and naltrexone, is proven effective. Yet, resistance persists. Tyler Yates’ tragic story highlights the danger of dismissing MAT based on unfounded beliefs. The future requires aggressive education campaigns to dispel myths and promote understanding of how these medications work.

Pro Tip: Advocate for MAT within your community. Share reliable information and support initiatives that expand access to these life-saving treatments. Learn the facts to counter misinformation with evidence.

The trend is towards greater integration of MAT into mainstream healthcare. Expect increased availability in primary care settings, mobile clinics (like North Carolina’s innovative program), and community health centers. Telehealth will also play a crucial role, extending reach to underserved areas and reducing barriers to access.

Data-Driven Decisions: Leveraging Insights for Effective Policy

North Carolina’s efforts to track overdose deaths and survey public perceptions are commendable. This data provides a roadmap for targeted interventions. In the future, expect more sophisticated data analytics to identify at-risk populations, evaluate the effectiveness of programs, and inform policy decisions. This includes a deeper understanding of social determinants of health, which significantly impact substance use patterns.

Real-Life Example: Cities and states are beginning to use predictive analytics to identify areas with high overdose rates and allocate resources accordingly. This proactive approach allows for timely interventions and saves lives. Explore the NC Opioid Settlement Dashboard to see local investment progress.

Artificial intelligence (AI) and machine learning may be used to detect early warning signs of relapse, personalize treatment plans, and optimize resource allocation. However, ethical considerations, especially regarding privacy, must be addressed when deploying these technologies.

Funding the Future: Strategic Investment of Opioid Settlement Funds

The influx of opioid settlement funds presents a unique opportunity to address the root causes of substance use disorder. As Alyssa Kitlas, Wake County’s opioid settlement program manager, emphasized, this is “a real opportunity to make an investment to end stigma.”

The trend is toward investing in prevention, treatment, and recovery support services. Expect funds to be allocated to expanding access to MAT, increasing the availability of naloxone (an overdose reversal medication), and supporting community-based programs.

Did you know? Opioid settlement funds can be used to support workforce development initiatives, providing individuals in recovery with job training and employment opportunities. This can reduce recidivism and improve long-term outcomes.

The Power of Collaboration: A Unified Approach

Addressing substance use disorder requires a collaborative effort involving healthcare providers, policymakers, community organizations, and individuals with lived experience. The future hinges on breaking down silos and fostering a unified approach. We can expect to see more integrated care models that combine medical, behavioral health, and social services.

Related Keywords: substance abuse, addiction recovery, opioid crisis, mental health, community support, harm reduction, public health

Efforts like the Wake County Drug Overdose Prevention Coalition show how different stakeholders can come together to address local needs. This model can be replicated and scaled up at the state and national levels. The goal is to create a seamless system of care that is accessible, affordable, and responsive to the needs of individuals and communities.

FAQ: Understanding Substance Use Disorder and Stigma

What is substance use disorder?
A chronic, relapsing brain disease characterized by compulsive drug seeking and use, despite harmful consequences.
Why is stigma a barrier to treatment?
Stigma leads to shame, fear of judgment, and discrimination, preventing people from seeking help.
What is medication-assisted treatment (MAT)?
The use of medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of substance use disorders.
Where can I find help for substance use disorder?
Contact your healthcare provider, local health department, or SAMHSA’s National Helpline at 1-800-662-HELP (4357).
How can I help reduce stigma?
Educate yourself and others, use respectful language, and share stories of recovery.

The future of substance use disorder treatment is bright. By embracing empathy, promoting evidence-based practices, and investing in collaborative solutions, we can create a society where recovery is not only possible but celebrated.

Learn more about substance use disorder at SAMHSA.

What are your thoughts on this issue? Share your comments below, explore more articles on our site, or subscribe to our newsletter for the latest updates.

July 29, 2025 0 comments
0 FacebookTwitterPinterestEmail
Business

Walgreens to pay $300 million to settle claims it illegally filled invalid opioids prescriptions

by Chief Editor April 22, 2025
written by Chief Editor

Understanding the Impacts of Big Pharmacy Settlements

The recent $300 million settlement by Walgreens Boots Alliance marks a significant moment in the ongoing battle against opioid misuse in the United States. This agreement resolves allegations of unlawfully filled prescriptions for opioids and other controlled substances over a decade. As we explore the potential future trends arising from such settlements, it’s crucial to understand their implications on public health, the pharmaceutical industry, and legal landscapes.

Increased Regulatory Scrutiny on Pharmacies

Following the settlement, one immediate trend is the heightened scrutiny on pharmacy chains by federal agencies. The Department of Justice’s involvement underscores a commitment to enforcing the Controlled Substances Act (CSA) and the False Claims Act (FCA). Pharmacies are expected to adopt stricter compliance protocols to prevent similar lawsuits, potentially involving more rigorous training for pharmacists and enhanced prescription monitoring programs.

Did you know? Enhanced regulatory oversight could lead to improved opioid dispensation practices, contributing to a reduction in the number of illegal prescriptions filled each year.

The Rising Tide of Litigation

Settlements like Walgreens’ could pave the way for increased litigation against pharmaceutical companies and pharmacies. Legal actions aim to hold entities accountable for their role in the opioid crisis, driving substantial financial penalties that may push the industry to reform.

In the past few years, many companies have faced similar lawsuits, with staggering fines as potential consequences. For instance, Purdue Pharma settled for billions of dollars in connection with the opioid crisis.

NYTimes – Purdue Pharma Opioid Settlement

Evolving Prescription Practices

Prescription practices within pharmacies are likely to evolve significantly as a preventive measure against future liabilities. Companies are investing in advanced analytics to identify suspicious prescription patterns, ensuring compliance with legal standards and mitigating risks associated with opioid distribution.

Pro Tip: Pharmacies might also collaborate more closely with healthcare providers to establish guidelines that distinguish legitimate from potentially harmful prescriptions.

Future Public Health Strategies

The opioid crisis remains a public health issue requiring coordinated efforts beyond legal settlements. Public health strategies are likely to focus more on prevention, education, and rehabilitation programs. This comprehensive approach may involve stakeholders ranging from government agencies to community organizations.

For example, President Trump’s initiatives, like the 20% tariff on China for fentanyl trafficking, reflect a broader strategy to curb illegal drug flows—a concern tied to public policy and international relations.

Frequently Asked Questions (FAQ)

What are the main allegations against pharmacies like Walgreens?

Pharmacies are alleged to have filled invalid prescriptions for opioids and controlled substances, violating federal laws such as the CSA and FCA.

How can increased regulatory scrutiny benefit the public?

Stricter oversight and compliance by pharmacies can reduce the number of illegal opioid prescriptions filled, mitigating public health risks.

Will the settlement affect prescription prices?

Increased regulatory demands and potential litigations may lead to higher costs for pharmacies, which could impact prescription prices depending on how companies absorb or pass on these expenses.

Conclusion and Call to Action

The ripple effects of the Walgreens settlement are pervasive, potentially transforming regulatory practices, prescription management, and public health strategies. As we continue to navigate the complexities of the opioid crisis, staying informed on these trends becomes ever more crucial.

Explore More: Interested in deep dives into related topics? Check out our latest coverage on the opioid crisis.

Do you have thoughts or questions about the future of pharmacy regulations? Share your insights in the comments below or subscribe to our newsletter for the latest updates.

April 22, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Claimant says opioid victims won’t get justice in proposed Purdue settlement

by Chief Editor March 10, 2025
written by Chief Editor

The Long Legal Battle of Purdue Pharma: Implications and Future Trends

The Purdue Pharma bankruptcy settlement has reignited ongoing debates about corporate accountability, the power of legal settlements, and the opioid crisis’s sustained impact. As we look ahead, several key trends could reshape this landscape.

The Evolving Legal Landscape for Pharmaceutical Companies

The legal battles surrounding Purdue Pharma highlight a broader trend towards increased scrutiny and accountability for pharmaceutical companies. In recent years, there has been a significant shift as legal systems push for more stringent penalties and transparency in corporate practices. Consider the case of Johnson & Johnson, which also faced massive settlements related to the opioid crisis, amounting to over $8 billion.

These cases signify a potential for more rigorous legal frameworks, where pharmaceutical companies might face higher stakes in litigation, as well as potential criminal charges against executives and board members, akin to those historically seen in corporate fraud cases.

Impact on Victims and Compensation Frameworks

Victims of the opioid crisis, represented by claims like those in the Purdue case, continue to battle for fair compensation. Traditionally, victim compensation has been limited or convoluted, but recent trends suggest potential shifts. The growing public and legislative pressure could lead to more victim-focused frameworks, as seen in recent legislative proposals aiming to create funds directly benefiting victims and their families without extensive legal gatekeeping.

Emerging Role of Corporate Social Responsibility (CSR)

CSR initiatives are becoming paramount in mitigating the fallout from such settlements. Pharmaceutical companies might accelerate their CSR programs, focusing more directly on community health initiatives and addiction treatment programs as part of their reparation efforts. Companies like Pfizer have started comprehensive rehabilitation support programs, reflecting a growing industry trend.

Evolution of Bankruptcy Strategies in Corporate America

The Purdue Pharma case has shed light on how corporations can use bankruptcy settlements strategically. This may trigger discussions on refining bankruptcy laws to prevent misuse by wealthy corporations while ensuring fair settlements for affected parties. As such, there’s potential for legislative changes aimed at creating a more level playing field in bankruptcy proceedings.

Trends in Media Reporting and Public Opinion

Media narratives around corporate malfeasance are increasingly shaping public opinion, influencing legal outcomes and regulatory actions. High-profile reporting, like the CBS News investigation into Purdue Pharma, helps inform the public and keeps pressure on legal and legislative systems to deliver justice.

For instance, stories highlighting absentee accountability foster a more informed and critical public, which in turn pushes policymakers to act decisively. As data integrity and investigative journalism improve, so will the quality of information available to the public.

FAQ Section

Q: How can victims ensure fair compensation in future settlements?

A: Advocacy for transparent distribution frameworks and active participation in legal proceedings can ensure more equitable compensation models for victims.

Q: Will other pharmaceutical companies face similar legal battles?

A: Given the ongoing scrutiny and evolving legal standards, it’s likely that more companies involved in questionable practices will face increased legal risks.

Looking Ahead: The Path to Justice and Reform

The Purdue Pharma case is a crucial turning point that speaks volumes about the potential for systemic change. Continuous oversight, robust legal frameworks, and increased corporate responsibility are pivotal in navigating future trends. Furthermore, by leveraging CSR effectively and incorporating ethical business practices, companies can regain public trust and contribute positively to societal health.

Pro Tip: Stay informed about legislative changes and public discourse regarding pharmaceutical accountability to understand how these trends might evolve.

What aspects of these developments interest you the most? Share your thoughts in the comments below or explore more articles on corporate accountability and legal reform.

March 10, 2025 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • Russia Claims Ukrainian Drones Entered Latvian Airspace and Hit Oil Tanks

    May 8, 2026
  • Trump Delays Planned Tariff Hike on EU Cars

    May 8, 2026
  • Guru Ngaji Paksa Anak Pakai Hijab? Cerita Lucu Nikita Willy vs. Guru yang Mengejutkan!

    May 8, 2026
  • Copa Libertadores: Medellín vs Flamengo Match Suspended Amid Fan Protests

    May 8, 2026
  • Pirelli Relaunches Iconic Scorpion BK Tires for the Lamborghini LM002

    May 8, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World